Exemestane Tablet
FDA Label NDC 70771-1374

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Exemestane (NDC 70771-1374). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

Package Label.Principal Display Panel

NDC 70771-1374-3 in bottle of 30 tablets

Exemestane Tablets, 25 mg

Rx only

30 tablets

Exemestane Tablets, 25 mg (76a1959c Fe58 4df5 9a01 8cb265f5c8aa 04)

Exemestane Tablets, 25 mg (76a1959c Fe58 4df5 9a01 8cb265f5c8aa 04)

* Please review the disclaimer below.